Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices), End Users & Region - Global Forecast to 2026
The global peripheral vascular devices market in terms of revenue was estimated to be worth $10.3 billion in 2021 and is poised to reach $13.4 billion by 2026, growing at a CAGR of 5.3% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is driven by rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases, favorable reimbursement scenario for peripheral vascular procedures, Increased number of product approvals, increased prevalence of diabetes, and rising rate of tobacco consumption.
To know about the assumptions considered for the study, Request for Free Sample Report
Peripheral Vascular Devices Market Dynamics
DRIVER: Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases
The rapid growth in the geriatric population is one of the major factors driving the demand for peripheral vascular devices as this population segment is at a greater risk of developing peripheral vascular diseases, such as atherosclerosis and aneurysms. According to the World Health Organization (WHO), by 2050, the world’s population of people aged 60 years and older will double to 2.1 billion as well as the number of persons aged 80 years or older will triple by 2050 to reach 426 million.
As a result, age, genetic, and lifestyle factors can lead to a buildup of plaque in the arteries. Globally, it is estimated that more than 200 million people are suffering from peripheral vascular diseases (Source: National Center for Biotechnology Information (NCBI), 2021). Furthermore, according to the American College of Cardiology 2020, peripheral arterial disease (PAD) affects 8.5 million individuals in the US, and the prevalence of these diseases rises with age and is greater than 20% in the patient population aged above 80 years.
OPPORTUNITY: High growth rate in the emerging markets
Emerging markets, such as China, India, Singapore, and Brazil, are expected to witness high growth in the coming years owing to the presence of less-stringent regulatory policies and low competition. In order to leverage the high-growth opportunities in these markets, manufacturers are strategically focusing on expanding their presence in these countries. Moreover, the increasing competition in mature markets is further compelling manufacturers to focus on emerging markets. In 2016, Medtronic (Ireland) opened its Asia Pacific regional headquarters in Singapore. This development will support and strengthen the company’s operations in 80 locations across the Asia Pacific region. Moreover, in 2017, iVascular SLU received approval from the Indian government to sell its products in the country. This helped the company in terms of revenue generation as well as expanding its presence in emerging economies.
CHALLENGE: Rise in the availability of alternative treatments
Anticoagulant medication is considered the first line of treatment for peripheral vascular diseases. The increasing efficacy of new-generation anticoagulants, such as Dabigatran, is resulting in their wide uptake and, in turn, creating major hindrances for the greater uptake of peripheral vascular devices. Also, medications, such as statins, are increasingly being used in the treatment of peripheral vascular diseases. The increasing use of these drugs may reduce the need for surgeries and thereby limit the use of peripheral vascular devices. Moreover, PAD can be treated with medication such as antiplatelet agents, vasodilators, cholesterol-lowering agents, angiotensin-converting enzyme inhibitors, or angiotensin-receptor blockers.
The Hemodynamic flow alteration devices segment is expected to grow at the highest CAGR, of peripheral vascular devices industry, during the forecast period
Based on the product, the global peripheral vascular devices market is segmented into angioplasty balloon, angioplasty stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, other peripheral vascular devices. The Embolic Protection Devices segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this market are increasing investments in new technology development and the growing number of regulatory approvals for these devices, and venture capital funding for the development of advanced EPDs .
Abdominal Aortic Aneurysm Stent Grafts accounted for the largest share of the peripheral vascular devices industry
Based on the product, the global peripheral vascular devices market is segmented into angioplasty balloon, angioplasty stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, other peripheral vascular devices. The Abdominal Aortic Aneurysm Stent Grafts accounted for the largest share of the global market in 2021. The increasing number of geriatric population and rising cases of hypertension are the major driving factor for this market.
North America accounted for the largest share of the peripheral vascular devices industry
Based on the region, the global peripheral vascular devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2021, North America accounted for the largest share of the global market. Growth in this market can be attributed to the growth in the geriatric population and the high prevalence of peripheral vascular diseases. Furthermore, the presence of key market players in this region ensures high access to medical devices
To know about the assumptions considered for the study, download the pdf brochure
Some of the major players operating in global peripheral vascular devices market are Medtronic (Ireland), Boston Scientific Corporation (US). In 2021, Medtronic (Ireland), held the leading position in the market. The company has a strong geographic presence across North America, Europe, and Asia Pacific. Boston Scientific Corporation (US) held the second position in the global market in 2021.
Scope of the Peripheral Vascular Devices Industry
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$10.3 billion |
|
Projected Revenue by 2026 |
$13.4 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 5.3% |
|
Market Driver |
Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases |
|
Market Opportunity |
High growth rate in the emerging markets |
This research report categorizes the peripheral vascular devices market to forecast revenue and analyze trends in each of the following submarkets:
By Product
-
Angioplasty Balloons
- Old/Normal
- Cutting and Scoring
- Drug-Eluting.
-
Angioplasty Stents
- Drug-eluting
-
Bare metal
- Self-expandable
- Balloon-expandable
-
Catheters
- Angiography
- IVUS/OCT
- Guiding
-
Endovascular Aneurysm Repair Stent Grafts
- Abdominal Aortic Aneurysm Stent Grafts
- Thoracic Aortic Aneurysm Stent Grafts
-
Inferior Vena Cava Filters
- Retrievable
- Permanent
-
Plaque Modification Devices
- Atherectomy
- Thrombectomy
-
Hemodynamic Flow Alteration Device Market
- Embolic Protection Devices
- Chronic Total Occlusion Devices
-
Other Peripheral Vascular Devices
- Guidewires
- Vascular Closure Devices
- Introducer Sheaths
- Balloon Information Devices
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Spain
- Italy
- RoE
-
Asia Pacific
- China
- Japan
- India
- RoAPAC
-
Rest of the World
-
Latin America
- Brazil
- Mexico
- Colombia
- Argentina
- Rest of Latin America
- Middle East & Africa
-
Latin America
Recent Developments of Peripheral Vascular Devices Industry
- In 2020, Medtronic received the US FDA approval for its IN. PACT AV drug-coated balloon (DCB) to treat arteriovenous fistula lesions
- In 2019, Boston Scientific Corporation received the FDA Approval for its VICI VENOUS STENT System for treating patients with deep venous blockages.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global peripheral vascular devices market?
The global peripheral vascular devices market boasts a total revenue value of $13.4 billion by 2026.
What is the estimated growth rate (CAGR) of the global peripheral vascular devices market?
The global peripheral vascular devices market has an estimated compound annual growth rate (CAGR) of 5.3% and a revenue size in the region of $10.3 billion in 2021.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 49)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 53)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGNS
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.1 GROWTH FORECAST
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
2.5 RISK ASSESSMENT
TABLE 1 RISKS
2.6 COVID-19 HEALTH ASSESSMENT
2.7 COVID-19 ECONOMIC ASSESSMENT
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY (Page No. - 66)
FIGURE 10 ANGIOPLASTY STENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 11 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 CATHETERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 18 GEOGRAPHIC SNAPSHOT OF THE GLOBAL PERIPHERAL VASCULAR DEVICES MARKET
4 PREMIUM INSIGHTS (Page No. - 72)
4.1 PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW
FIGURE 19 INCREASING PREVALENCE OF PERIPHERAL VASCULAR DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
4.2 GLOBAL MARKET, BY TYPE
FIGURE 20 DRUG-ELUTING STENT PRODUCTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021
4.3 NORTH AMERICA: MARKET, BY TYPE OF ANGIOPLASTY STENT AND COUNTRY
FIGURE 21 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
4.4 GLOBAL MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 75)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases
TABLE 2 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030
5.2.1.2 Favorable reimbursement scenario for peripheral vascular procedures
TABLE 3 REIMBURSEMENT FOR PERIPHERAL VASCULAR PROCEDURES IN THE US
5.2.1.3 Increased number of product approvals
TABLE 4 PRODUCT APPROVALS IN THE GLOBAL MARKET, 2017–2021
5.2.1.4 Increased prevalence of diabetes
TABLE 5 DIABETES POPULATION, BY REGION, 2019 VS. 2030
5.2.1.5 Rising rate of tobacco consumption
TABLE 6 THE TOP 10 COUNTRIES WITH THE HIGHEST SMOKING RATE (2021)
5.2.1.6 Growth in the incidence of obesity
TABLE 7 OBESITY RATE IN THE DEVELOPED COUNTRIES (2021)
5.2.2 RESTRAINTS
5.2.2.1 Increased number of product failures and recalls
5.2.3 OPPORTUNITIES
5.2.3.1 High growth rate in the emerging markets
5.2.4 CHALLENGES
5.2.4.1 Rise in the availability of alternative treatments
5.2.4.2 Dearth of skilled professionals with expertise in peripheral vascular devices
5.2.5 IMPACT OF THE COVID-19 PANDEMIC ON THE GLOBAL MARKET
5.3 RANGES/SCENARIOS
5.3.1 GLOBAL MARKET
FIGURE 24 PESSIMISTIC SCENARIO
FIGURE 25 OPTIMISTIC SCENARIO
FIGURE 26 REALISTIC SCENARIO
5.4 VALUE CHAIN ANALYSIS
FIGURE 27 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 28 DIRECT DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 INTENSITY OF COMPETITIVE RIVALRY
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 BARGAINING POWER OF SUPPLIERS
5.6.5 THREAT OF SUBSTITUTES
5.7 TECHNOLOGY ANALYSIS
5.8 REGULATORY ANALYSIS
5.9 PATENT ANALYSIS
5.10 TRADE ANALYSIS
TABLE 8 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 9 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 10 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 11 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION)
5.11 PRICING ANALYSIS
TABLE 12 PRICE RANGE FOR PERIPHERAL VASCULAR DEVICES
5.12 ECOSYSTEM MAPPING
5.12.1 ROLE IN ECOSYSTEM
FIGURE 29 KEY PLAYERS IN THE PERIPHERAL VASCULAR DEVICE ECOSYSTEM
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.13.1 REVENUE SHIFT AND REVENUE POCKETS FOR GLOBAL MARKET
5.13.2 REVENUE SHIFT FOR PERIPHERAL VASCULAR DEVICES
6 ANGIOPLASTY BALLOONS MARKET, BY TYPE (Page No. - 95)
6.1 INTRODUCTION
TABLE 13 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 15 ANGIOPLASTY BALLOONS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 16 ANGIOPLASTY BALLOONS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2 OLD/NORMAL BALLOONS
6.2.1 OLD/NORMAL BALLOONS TO DOMINATE THE ANGIOPLASTY BALLOONS MARKET
TABLE 17 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 18 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.3 DRUG-ELUTING BALLOONS
6.3.1 DRUG-ELUTING BALLOONS TO WITNESS THE HIGHEST GROWTH IN THE ANGIOPLASTY BALLOONS MARKET
TABLE 19 DRUG-ELUTING BALLOONS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 20 DRUG-ELUTING BALLOONS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.4 CUTTING AND SCORING BALLOONS
6.4.1 USE OF CUTTING BALLOONS IS LIMITED SINCE MEDICATION IS CONSIDERED THE PRIMARY TREATMENT FOR ATHEROSCLEROSIS
TABLE 21 CUTTING AND SCORING BALLOONS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 22 CUTTING AND SCORING BALLOONS MARKET, BY REGION, 2021–2026 (USD MILLION)
7 ANGIOPLASTY STENTS MARKET, BY TYPE (Page No. - 101)
7.1 INTRODUCTION
TABLE 23 ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 24 ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 25 ANGIOPLASTY STENTS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 26 ANGIOPLASTY STENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
7.2 DRUG-ELUTING STENTS
7.2.1 DRUG-ELUTING STENTS TO WITNESS A HIGHER ADOPTION DUE TO THE REDUCED RESTENOSIS RATE
TABLE 27 DRUG-ELUTING STENTS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 28 DRUG-ELUTING STENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
7.3 BARE-METAL STENTS
7.3.1 INCREASING USE OF DRUG-ELUTING STENTS TO RESTRAIN MARKET GROWTH
TABLE 29 BARE-METAL STENTS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 30 BARE-METAL STENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
7.3.2 BARE-METAL STENTS, BY DELIVERY PLATFORM
TABLE 31 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM, 2016–2020 (USD MILLION)
TABLE 32 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM, 2021–2026 (USD MILLION)
7.3.2.1 Balloon-expandable stents
TABLE 33 BALLOON-EXPANDABLE STENTS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 34 BALLOON-EXPANDABLE STENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
7.3.2.2 Self-expandable stents
TABLE 35 SELF-EXPANDABLE STENTS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 36 SELF-EXPANDABLE STENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
8 CATHETERS MARKET, BY TYPE (Page No. - 109)
8.1 INTRODUCTION
TABLE 37 CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 38 CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 39 CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 40 CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION)
8.2 ANGIOGRAPHY CATHETERS
8.2.1 ANGIOGRAPHY CATHETERS TO DOMINATE THE CATHETERS MARKET
TABLE 41 ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 42 ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION)
8.3 GUIDING CATHETERS
8.3.1 GUIDING CATHETERS TO ACCOUNT FOR THE SECOND-LARGEST SHARE OF THE CATHETERS MARKET
TABLE 43 GUIDING CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 44 GUIDING CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION)
8.4 IVUS/OCT CATHETERS
8.4.1 IVUS/OCT CATHETERS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE
TABLE 45 IVUS/OCT CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 46 IVUS/OCT CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION)
9 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE (Page No. - 115)
9.1 INTRODUCTION
TABLE 47 EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 48 EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 49 EVAR STENT GRAFTS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 50 EVAR STENT GRAFTS MARKET, BY REGION, 2021–2026 (USD MILLION)
9.2 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS
9.2.1 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS TO DOMINATE THE MARKET
TABLE 51 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 52 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION, 2021–2026 (USD MILLION)
9.3 THORACIC AORTIC ANEURYSM STENT GRAFTS
9.3.1 INCREASING INCIDENCE OF THORACIC AORTIC ANEURYSMS TO DRIVE MARKET GROWTH IN THE COMING YEARS
TABLE 53 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 54 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION, 2021–2026 (USD MILLION)
10 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE (Page No. - 120)
10.1 INTRODUCTION
TABLE 55 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 56 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 57 INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 58 INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2021–2026 (USD MILLION)
10.2 RETRIEVABLE FILTERS
10.2.1 RETRIEVABLE FILTERS SEGMENT TO REGISTER A HIGHER GROWTH RATE
TABLE 59 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 60 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2021–2026 (USD MILLION)
10.3 PERMANENT FILTERS
10.3.1 RISKS ASSOCIATED WITH PERMANENT FILTERS TO HAMPER THEIR SALES DURING THE FORECAST PERIOD
TABLE 61 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 62 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2021–2026 (USD MILLION)
11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE (Page No. - 125)
11.1 INTRODUCTION
TABLE 63 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 64 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 65 PLAQUE MODIFICATION DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 66 PLAQUE MODIFICATION DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
11.2 ATHERECTOMY DEVICES
11.2.1 INCREASING INCIDENCE OF ATHEROSCLEROSIS AS A RESULT OF THE RISING GLOBAL PREVALENCE OF OBESITY TO DRIVE THE MARKET
TABLE 67 ATHERECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 68 ATHERECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
11.3 THROMBECTOMY DEVICES
11.3.1 GROWING DVT INCIDENCE TO DRIVE THE ADOPTION OF THROMBECTOMY DEVICES
TABLE 69 THROMBECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 70 THROMBECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE (Page No. - 130)
12.1 INTRODUCTION
TABLE 71 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 72 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
12.2 EMBOLIC PROTECTION DEVICES
12.2.1 INCREASING INVESTMENTS IN NEW TECHNOLOGY AND INCREASING REGULATORY APPROVALS TO DRIVE MARKET GROWTH
TABLE 73 EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 74 EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
12.3 CHRONIC TOTAL OCCLUSION (CTO) DEVICES
12.3.1 INCREASING INVESTMENTS IN THE DEVELOPMENT OF CTO DEVICES TO DRIVE MARKET GROWTH
TABLE 75 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 76 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
13 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE (Page No. - 134)
13.1 INTRODUCTION
TABLE 77 GLOBAL MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 78 GLOBAL MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 79 GLOBAL MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 80 GLOBAL MARKET, BY REGION, 2021–2026 (USD MILLION)
13.2 GUIDEWIRES
TABLE 81 GUIDEWIRES MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 82 GUIDEWIRES MARKET, BY REGION, 2021–2026 (USD MILLION)
13.3 VASCULAR CLOSURE DEVICES
TABLE 83 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 84 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
13.4 INTRODUCER SHEATHS
TABLE 85 INTRODUCER SHEATHS MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 86 INTRODUCER SHEATHS MARKET, BY REGION, 2021–2026 (USD MILLION)
13.5 BALLOON INFLATION DEVICES
TABLE 87 BALLOON INFLATION DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 88 BALLOON INFLATION DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
14 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION (Page No. - 141)
14.1 INTRODUCTION
TABLE 89 GLOBAL MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 90 GLOBAL MARKET, BY REGION, 2021–2026 (USD MILLION)
14.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: MARKET SNAPSHOT
TABLE 91 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 92 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 93 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 94 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 95 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 96 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 97 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 98 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 99 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 100 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 101 NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 102 NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 103 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 104 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 105 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 106 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 107 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 108 NORTH AMERICA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.2.1 FAVORABLE REIMBURSEMENT SCENARIO TO ENSURE DEVICE ADOPTION IN THE US
TABLE 109 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 110 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 111 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 112 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 113 US: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 114 US: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 115 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 116 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 117 US: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 118 US: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 119 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 120 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 121 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 122 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 123 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 124 US: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.2.2 CANADA
14.2.2.1 Rising prevalence of target diseases to drive market growth
TABLE 125 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 126 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 127 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 128 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 129 CANADA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 130 CANADA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 131 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 132 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 133 CANADA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 134 CANADA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 135 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 136 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 137 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 138 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 139 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 140 CANADA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.3 EUROPE
TABLE 141 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 142 EUROPE: MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 143 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 144 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 145 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 146 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 147 EUROPE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 148 EUROPE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 149 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 150 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 151 EUROPE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 152 EUROPE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 153 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 154 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 155 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 156 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 157 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 158 EUROPE: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.3.1 GERMANY
14.3.1.1 Increase in geriatric and obese populations contribute to device demand
TABLE 159 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 160 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 161 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 162 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 163 GERMANY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 164 GERMANY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 165 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 166 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 167 GERMANY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 168 GERMANY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 169 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 170 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 171 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 172 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 173 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 174 GERMANY: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.3.2 FRANCE
14.3.2.1 Incidence of PE and DVT to increase owing to the growth of France’s geriatric population
TABLE 175 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 176 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 177 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 178 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 179 FRANCE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 180 FRANCE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 181 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 182 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 183 FRANCE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 184 FRANCE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 185 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 186 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 187 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 188 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 189 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 190 FRANCE: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.3.3 UK
14.3.3.1 Increasing incidence of peripheral vascular diseases to support market growth in the UK
TABLE 191 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 192 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 193 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 194 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 195 UK: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 196 UK: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 197 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 198 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 199 UK: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 200 UK: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 201 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 202 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 203 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 204 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 205 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 206 UK: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.3.4 SPAIN
14.3.4.1 Rising geriatric population to increase the demand for peripheral vascular devices
TABLE 207 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 208 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 209 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 210 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 211 SPAIN: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 212 SPAIN: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 213 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 214 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 215 SPAIN: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 216 SPAIN: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 217 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 218 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 219 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 220 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 221 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 222 SPAIN: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.3.5 ITALY
14.3.5.1 Increasing health expenditure and rising diabetes prevalence to drive market growth
TABLE 223 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 224 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 225 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 226 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 227 ITALY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 228 ITALY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 229 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 230 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 231 ITALY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 232 ITALY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 233 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 234 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 235 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 236 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 237 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 238 ITALY: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.3.6 REST OF EUROPE
TABLE 239 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
TABLE 240 ROE: PERCENTAGE OF GERIATRIC POPULATION TO THE TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030 (MILLION)
TABLE 241 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 242 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 243 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 244 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 245 ROE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 246 ROE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 247 ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 248 ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 249 ROE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 250 ROE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 251 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 252 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 253 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 254 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 255 ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 256 ROE: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.4 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 257 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 258 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 259 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 260 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 261 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 262 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 263 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 264 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 265 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 266 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 267 ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 268 ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 269 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 270 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 271 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 272 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 273 ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 274 ASIA PACIFIC: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.4.1 JAPAN
14.4.1.1 Presence of a large geriatric population to support market growth
TABLE 275 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 276 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 277 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 278 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 279 JAPAN: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 280 JAPAN: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 281 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 282 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 283 JAPAN: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 284 JAPAN: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 285 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 286 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 287 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 288 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 289 JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 290 JAPAN: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.4.2 CHINA
14.4.2.1 Growing target patient population to drive market growth
TABLE 291 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 292 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 293 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 294 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 295 CHINA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 296 CHINA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 297 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 298 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 299 CHINA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 300 CHINA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 301 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 302 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 303 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 304 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 305 CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 306 CHINA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.4.3 INDIA
14.4.3.1 Increasing prevalence of diabetes to drive the adoption of peripheral vascular devices
TABLE 307 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 308 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 309 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 310 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 311 INDIA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 312 INDIA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 313 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 314 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 315 INDIA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 316 INDIA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 317 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 318 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 319 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 320 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 321 INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 322 INDIA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.4.4 REST OF ASIA PACIFIC
TABLE 323 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 325 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 327 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 328 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 329 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 330 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 331 REST OF ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 332 REST OF ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 333 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 334 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 335 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 336 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 337 REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 338 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.5 REST OF THE WORLD
TABLE 339 ROW: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)
TABLE 340 ROW: MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 341 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 342 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 343 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 344 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 345 ROW: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 346 ROW: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 347 ROW: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 348 ROW: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 349 ROW: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 350 ROW: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 351 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 352 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 353 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 354 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 355 ROW: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 356 ROW: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.5.1 LATIN AMERICA
TABLE 357 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 358 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 359 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 360 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 361 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 362 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 363 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 364 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 365 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 366 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 367 LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 368 LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 369 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 370 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 371 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 372 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 373 LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 374 LATIN AMERICA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.5.1.1 Brazil
14.5.1.1.1 Brazil to dominate the Latin American peripheral vascular devices market
TABLE 375 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020(USD MILLION)
TABLE 376 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 377 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 378 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 379 BRAZIL: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 380 BRAZIL: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 381 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 382 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 383 BRAZIL: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 384 BRAZIL: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 385 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 386 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 387 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 388 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 389 BRAZIL: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 390 BRAZIL: MARKET, BY TYPE, 2026–2026 (USD MILLION)
14.5.1.2 Mexico
14.5.1.2.1 Mexico to account for the second-largest share in the Latin American peripheral vascular devices market
TABLE 391 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 392 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 393 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 394 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 395 MEXICO: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 396 MEXICO: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 397 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 398 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 399 MEXICO: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 400 MEXICO: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 401 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 402 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 403 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 404 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 405 MEXICO: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 406 MEXICO: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.5.1.3 Colombia
14.5.1.3.1 Increasing prevalence of peripheral artery diseases to support market growth
TABLE 407 COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 408 COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 409 COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 410 COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 411 COLOMBIA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 412 COLOMBIA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 413 COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 414 COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 415 COLOMBIA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 416 COLOMBIA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 417 COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 418 COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 419 COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 420 COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 421 COLOMBIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 422 COLOMBIA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.5.1.4 Argentina
14.5.1.4.1 Increasing prevalence of obesity to support market growth
TABLE 423 ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 424 ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 425 ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 426 ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 427 ARGENTINA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 428 ARGENTINA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 429 ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 430 ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 431 ARGENTINA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 432 ARGENTINA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 433 ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 434 ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 435 ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 436 ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 437 ARGENTINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 438 ARGENTINA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.5.1.5 Rest of Latin America
TABLE 439 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 440 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 441 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 442 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 443 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 444 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 445 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 446 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 447 REST OF LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 448 REST OF LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 449 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 450 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 451 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 452 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 453 REST OF LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 454 REST OF LATIN AMERICA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
14.5.2 MIDDLE EAST & AFRICA
14.5.2.1 Increasing prevalence of diabetes to drive market growth
TABLE 455 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 456 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 457 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 458 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 459 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 460 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 461 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 462 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 463 MIDDLE EAST & AFRICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 464 MIDDLE EAST & AFRICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 465 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 466 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 467 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 468 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 469 MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 470 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
15 COMPETITIVE LANDSCAPE (Page No. - 267)
15.1 OVERVIEW
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 471 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE PERIPHERAL VASCULAR DEVICES MARKET
15.3 MARKET SHARE ANALYSIS
TABLE 472 GLOBAL MARKET: DEGREE OF COMPETITION
15.4 COMPANY EVALUATION MATRIX
15.4.1 STARS
15.4.2 EMERGING LEADERS
15.4.3 PERVASIVE PLAYERS
15.4.4 PARTICIPANTS
FIGURE 32 COMPANY EVALUATION MATRIX: GLOBAL MARKET
15.5 COMPANY EVALUATION MATRIX (SMES/START-UPS)
15.5.1 PROGRESSIVE COMPANIES
15.5.2 STARTING BLOCKS
15.5.3 RESPONSIVE COMPANIES
15.5.4 DYNAMIC COMPANIES
FIGURE 33 COMPANY EVALUATION MATRIX: GLOBAL MARKET (SMES & START-UPS)
15.6 COMPANY FOOTPRINT ANALYSIS
TABLE 473 OVERALL FOOTPRINT OF COMPANIES IN THE GLOBAL MARKET
TABLE 474 PRODUCT FOOTPRINT OF COMPANIES
15.7 COMPETITIVE SCENARIO
16 COMPANY PROFILES (Page No. - 280)
16.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1.1 MEDTRONIC
TABLE 475 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT (2020)
16.1.2 BOSTON SCIENTIFIC CORPORATION
TABLE 476 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 35 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2020)
16.1.3 ABBOTT
TABLE 477 ABBOTT: BUSINESS OVERVIEW
FIGURE 36 ABBOTT: COMPANY SNAPSHOT (2020)
16.1.4 BECTON, DICKINSON AND COMPANY
TABLE 478 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
16.1.5 TERUMO CORPORATION
TABLE 479 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 38 TERUMO CORPORATION: COMPANY SNAPSHOT (2020)
16.1.6 CORDIS (A SUBSIDIARY OF CARDINAL HEALTH)
TABLE 480 CORDIS: BUSINESS OVERVIEW
FIGURE 39 CARDINAL HEALTH: COMPANY SNAPSHOT (2020)
16.1.7 B. BRAUN MELSUNGEN AG
TABLE 481 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 40 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
16.1.8 MERIT MEDICAL SYSTEMS
TABLE 482 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
FIGURE 41 MERIT MEDICAL: COMPANY SNAPSHOT (2020)
16.1.9 PENUMBRA, INC.
TABLE 483 PENUMBRA, INC: BUSINESS OVERVIEW
FIGURE 42 PENUMBRA, INC.: COMPANY SNAPSHOT (2020)
16.1.10 KONINKLIJKE PHILIPS N.V.
TABLE 484 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
16.1.11 IVASCULAR S.L.U.
TABLE 485 IVASCULAR S.L.U.: BUSINESS OVERVIEW
16.1.12 BIOSENSORS INTERNATIONAL GROUP, LTD.
TABLE 486 BIOSENSORS INTERNATIONAL GROUP, LTD.: BUSINESS OVERVIEW
16.1.13 BIOTRONIK
TABLE 487 BIOTRONIK: BUSINESS OVERVIEW
16.1.14 AMG INTERNATIONAL GMBH (A SUBSIDIARY OF Q3 MEDICAL)
TABLE 488 AMG INTERNATIONAL: BUSINESS OVERVIEW
16.1.15 ENDOCOR GMBH
TABLE 489 ENDOCOR GMBH: BUSINESS OVERVIEW
16.2 START-UPS/SME PLAYERS
16.2.1 MERIL LIFE SCIENCES PVT. LTD.
TABLE 490 MERIL LIFE SCIENCES PVT.LTD.: COMPANY OVERVIEW
16.2.2 ALVIMEDICA
TABLE 491 ALVIMEDICA: COMPANY OVERVIEW
16.2.4 CARDIONOVUM GMBH
TABLE 492 CARDIONOVUM GMBH: COMPANY OVERVIEW
16.2.6 SMT
TABLE 493 SMT: COMPANY OVERVIEW
16.2.8 MEDINOL LTD.
TABLE 494 MEDINOL LTD.: COMPANY OVERVIEW
16.2.9 ANDRAMED GMBH.
TABLE 495 ANDRAMED GMBH: COMPANY OVERVIEW
16.2.10 COOK
TABLE 496 COOK: COMPANY OVERVIEW
16.2.12 REX MEDICAL
TABLE 497 REX MEDICAL: COMPANY OVERVIEW
16.2.14 QMD
TABLE 498 QMD.: COMPANY OVERVIEW
16.2.15 BROSMED MEDICAL
TABLE 499 BROSMED MEDICAL: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 APPENDIX (Page No. - 339)
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 AVAILABLE CUSTOMIZATIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
The study involved four major activities in estimating the current size of the peripheral vascular devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (hospitals, cardiologist, cardiology surgeon) and supply sides (peripheral vascular devices manufacturers and distributors).
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the peripheral vascular devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the peripheral vascular devices industry.
Report Objectives
- To define, describe, and forecast the global peripheral vascular devices market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, new product launches, and partnerships in the peripheral vascular devices market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis:
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis:
- Further breakdown of Rest of the World peripheral vascular devices market into specific countries peripheral vascular devices market and further breakdown of the European peripheral vascular devices market into specific countries
Growth drivers for Peripheral Intervention Business from macro to micro
Peripheral intervention refers to medical procedures that are performed on the blood vessels and other parts of the peripheral vascular system outside of the heart and brain. The peripheral intervention business is expected to experience significant growth in the coming years due to several macro and micro factors. Here are some of the growth drivers for the peripheral intervention business:
Macro Drivers:
Increasing prevalence of peripheral vascular diseases: The growing prevalence of peripheral vascular diseases such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and venous insufficiency is expected to drive the demand for peripheral interventions.
Aging population: The global population is aging, with a growing number of people over the age of 65. This demographic trend is expected to increase the incidence of peripheral vascular diseases, as older adults are more likely to develop these conditions.
Technological advancements: Technological advancements in peripheral intervention procedures, such as the development of new medical devices and imaging technologies, are expected to improve the efficacy and safety of these procedures, driving demand for peripheral interventions.
Increasing healthcare expenditure: Increasing healthcare expenditure, particularly in developing countries, is expected to drive demand for peripheral interventions, as more people have access to medical care and treatment.
Micro Drivers:
Minimally invasive procedures: Minimally invasive peripheral intervention procedures, such as endovascular interventions, are becoming increasingly popular as they are less invasive and have shorter recovery times than traditional surgical procedures.
Rising demand for outpatient procedures: The trend towards outpatient procedures is expected to drive demand for peripheral interventions, as these procedures can be performed in a less costly and more convenient outpatient setting.
Increasing focus on preventative care: There is a growing focus on preventative care, particularly in the management of chronic diseases such as diabetes and hypertension, which are risk factors for peripheral vascular diseases. This is expected to drive demand for peripheral interventions aimed at preventing and managing these conditions.
Growing demand for personalized medicine: The trend towards personalized medicine, where treatments are tailored to the individual patient, is expected to drive demand for peripheral interventions, as these procedures can be customized to meet the specific needs of each patient.
Market outlook for the top 10 companies in Peripheral Intervention Market
Abbott Laboratories: Abbott Laboratories is a leading player in the Peripheral Intervention market, with a strong portfolio of products for treating peripheral vascular diseases. The company's product portfolio includes devices for peripheral artery disease (PAD) treatment, such as stents, balloon catheters, and atherectomy devices. Abbott Laboratories is expected to continue to grow its market share through product innovation and acquisitions.
Boston Scientific Corporation: Boston Scientific is a global leader in the medical device industry, with a strong presence in the Peripheral Intervention market. The company offers a broad range of products for peripheral vascular interventions, including stents, balloons, and embolic protection devices. Boston Scientific is expected to continue to grow through product innovation and strategic acquisitions.
Medtronic plc: Medtronic is a leading medical device company with a strong presence in the Peripheral Intervention market. The company offers a range of products for peripheral vascular interventions, including stents, balloons, and embolic protection devices. Medtronic is expected to continue to grow through product innovation and expansion into new markets.
Koninklijke Philips N.V.: Koninklijke Philips is a global healthcare company that offers a range of medical devices, including imaging equipment for peripheral vascular interventions. The company's product portfolio includes ultrasound systems, CT scanners, and MRI machines. Koninklijke Philips is expected to continue to grow through product innovation and expansion into new markets.
C.R. Bard, Inc.: C.R. Bard is a leading medical device company with a strong presence in the Peripheral Intervention market. The company offers a range of products for peripheral vascular interventions, including stents, balloons, and catheters. C.R. Bard is expected to continue to grow through product innovation and expansion into new markets.
Cook Medical Incorporated: Cook Medical is a global medical device company that offers a range of products for peripheral vascular interventions, including stents, balloons, and catheters. The company is known for its commitment to product innovation and is expected to continue to grow through new product development and expansion into new markets.
Terumo Corporation: Terumo is a leading medical device company with a strong presence in the Peripheral Intervention market. The company offers a range of products for peripheral vascular interventions, including stents, balloons, and catheters. Terumo is expected to continue to grow through product innovation and expansion into new markets.
B. Braun Melsungen AG: B. Braun is a global healthcare company that offers a range of medical devices, including products for peripheral vascular interventions. The company's product portfolio includes stents, balloons, and catheters. B. Braun is expected to continue to grow through product innovation and expansion into new markets.
Cardinal Health, Inc.: Cardinal Health is a global healthcare company that offers a range of medical devices, including products for peripheral vascular interventions. The company's product portfolio includes stents, balloons, and catheters. Cardinal Health is expected to continue to grow through product innovation and expansion into new markets.
Endologix, Inc.: Endologix is a medical device company that specializes in the treatment of aortic disorders. The company's product portfolio includes stent grafts for the treatment of abdominal aortic aneurysms (AAAs). Endologix is expected to continue to grow through product innovation and expansion into new markets.
Future trends that can impact the Peripheral Intervention Market
Technological advancements: With the advent of new technologies, such as artificial intelligence, 3D printing, and robotics, the Peripheral Intervention market is expected to see a surge in demand for advanced and innovative medical devices.
Growing preference for minimally invasive procedures: Patients are increasingly preferring minimally invasive procedures for the treatment of peripheral vascular diseases, as they are associated with shorter hospital stays, faster recovery times, and fewer complications.
Rising prevalence of chronic diseases: The increasing incidence of chronic diseases such as diabetes, obesity, and hypertension is expected to drive demand for peripheral intervention procedures and devices.
Aging population: The growing aging population is likely to drive demand for peripheral intervention procedures, as older adults are more susceptible to peripheral vascular diseases.
Increased focus on value-based care: The shift towards value-based care and the emphasis on reducing healthcare costs is expected to drive the adoption of cost-effective peripheral intervention procedures and devices.
Expansion in emerging markets: The growth of emerging markets, such as China, India, and Brazil, is expected to create new opportunities for the Peripheral Intervention market, as these countries have large patient populations and increasing healthcare spending.
Generating Response ...
Growth opportunities and latent adjacency in Peripheral Vascular Devices Market